Siegfried Holding AG (LON:0QQO)

Market Cap	3.94B +4.0%
Revenue (ttm)	1.19B +0.8%
Net Income	141.43M +19.2%
EPS	3.23 +17.5%
Shares Out	n/a
PE Ratio	27.85
Forward PE	23.63
Dividend	0.35 (0.36%)
Ex-Dividend Date	Apr 22, 2025

Volume	3,094
Average Volume	30,597
Open	93.95
Previous Close	94.70
Day's Range	92.10 - 94.40
52-Week Range	59.10 - 107.20
Beta	0.80
RSI	62.87
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1873
• Employees: 3,926
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QQO

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.

Financial numbers in CHF